Corpus ID: 10234921

hu1124 (Genentech).

  title={hu1124 (Genentech).},
  author={H. Granlund},
  journal={IDrugs : the investigational drugs journal},
  volume={3 10},
  • H. Granlund
  • Published 2000
  • Medicine
  • IDrugs : the investigational drugs journal
Genentech and XOMA are collaborating in the development of a humanized monoclonal antibody, hu1124 (anti-CD11a), which has the potential to treat psoriasis and prevent organ transplant rejection. It is currently undergoing phase III clinical trials for psoriasis and phase I/II trials for transplant rejection. A phase II trial in moderate-to severe psoriasis patients was completed in January 1999 and data were initially presented at the Canadian Dermatology Association meeting in Vancouver, BC… Expand